132 related articles for article (PubMed ID: 23231733)
21. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
22. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
[TBL] [Abstract][Full Text] [Related]
23. Scleromyxoedema: the importance of physical examination.
Pipa S; Sá J; Mondragão A; Marinho A
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317211
[No Abstract] [Full Text] [Related]
24. Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.
Yeung CK; Loong F; Kwong YL
Br J Haematol; 2012 May; 157(4):411. PubMed ID: 22429092
[No Abstract] [Full Text] [Related]
25. Scleromyxedema.
Hummers LK
Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
[TBL] [Abstract][Full Text] [Related]
26. Case of erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with thalidomide and plasma exchange.
Manni E; Cervadoro E; Papineschi F
Ther Apher Dial; 2015 Apr; 19(2):195-6. PubMed ID: 25257541
[No Abstract] [Full Text] [Related]
27. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
[TBL] [Abstract][Full Text] [Related]
28. Lichen myxedematosus: a case series focusing on clinical features, disease associations, and management.
Atci T; Yazganoglu KD; Yonal I; Ekinci AP; Kaplan SG; Babuna G; Besisik S; Baykal C
J Dtsch Dermatol Ges; 2017 Feb; 15(2):215-218. PubMed ID: 28084678
[No Abstract] [Full Text] [Related]
29. A case of atypical scleromyxedema without gammopathy treated with cyclosporine.
Açikgöz G; Özmen I; Hüseynov S; Gamsizkan M; Çaliskan E; Arca E; Koç E
Indian J Dermatol Venereol Leprol; 2014; 80(3):278. PubMed ID: 24823421
[No Abstract] [Full Text] [Related]
30. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
Rey JB; Luria RB
J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
[TBL] [Abstract][Full Text] [Related]
31. Treatment of localized lichen myxedematosus of discrete type with tacrolimus ointment.
Rongioletti F; Zaccaria E; Cozzani E; Parodi A
J Am Acad Dermatol; 2008 Mar; 58(3):530-2. PubMed ID: 18280368
[No Abstract] [Full Text] [Related]
32. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
[TBL] [Abstract][Full Text] [Related]
33. Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
Migkou M; Gkotzamanidou M; Terpos E; Dimopoulos MA; Kastritis E
Leuk Res; 2011 Nov; 35(11):e209-11. PubMed ID: 21831425
[No Abstract] [Full Text] [Related]
34. [Scleromyxedema with neurological symptoms: successful treatment with immunoglobulins].
Manríquez J; Berroeta-Mauriziano D; Andino-Navarrete R; Vera-Kellet C
Med Clin (Barc); 2015 Jan; 144(1):47-8. PubMed ID: 24656121
[No Abstract] [Full Text] [Related]
35. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
Letzelter M; Grimaux X
Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide treatment for refractory HIV-associated colitis: a case series.
Johnson L; Jarvis JN; Wilkins EG; Hay PE
Clin Infect Dis; 2008 Jul; 47(1):133-6. PubMed ID: 18494607
[TBL] [Abstract][Full Text] [Related]
37. Atypical case of discrete papular mucinosis involving acral and nuchal regions in an adult.
Zeng YP; Ma DL
J Dtsch Dermatol Ges; 2012 Apr; 10(4):266-7. PubMed ID: 22313743
[No Abstract] [Full Text] [Related]
38. Scleromyxedema treatment: a systematic review and update.
Haber R; Bachour J; El Gemayel M
Int J Dermatol; 2020 Oct; 59(10):1191-1201. PubMed ID: 32358980
[TBL] [Abstract][Full Text] [Related]
39. Thalidomide in oral Crohn's disease refractory to conventional medical treatment.
Odeka EB; Miller V
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926
[No Abstract] [Full Text] [Related]
40. Recalcitrant erosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment.
Eisman S; Orteu CH
Clin Exp Dermatol; 2004 May; 29(3):268-70. PubMed ID: 15115508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
